Back

SGLT2 inhibitors across the spectrum of heart failure.

29 August 2022 (13:00 - 13:10)
Organised by:
Congress Presentation Part of: SGLT-2 inhibitors - Another piece of the puzzle in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) Open Access ESC Congress 2022

About the speaker

Photo
Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
Practical considerations for treating HF with mildly reduced and preserved EF.
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Implementing best practices across the spectrum of heart failure.
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Summary.
Slides Video
Presentation thumbnail
Discussion.
Video

Access the full session

Session thumbnail
SGLT-2 inhibitors - Another piece of the puzzle in heart failure
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 13:00 CET
You may be interested in
thumbnail
Congress Presentation
A patient with HF and LVEF > 40%: SGLT2 inhibitors.
27 August 2022
thumbnail
Congress Presentation
A Pre-Specified Meta-Analysis of DELIVER and EMPEROR-Preserved.
27 August 2022
thumbnail
Congress Presentation
SGLT2i is indicated for all HFpEF patients - pro.
23 May 2022
thumbnail
Congress Presentation
Chronic heart failure.
24 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources